JP2024509625A5 - - Google Patents
Info
- Publication number
- JP2024509625A5 JP2024509625A5 JP2023556473A JP2023556473A JP2024509625A5 JP 2024509625 A5 JP2024509625 A5 JP 2024509625A5 JP 2023556473 A JP2023556473 A JP 2023556473A JP 2023556473 A JP2023556473 A JP 2023556473A JP 2024509625 A5 JP2024509625 A5 JP 2024509625A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- membered
- hydrogen
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161141P | 2021-03-15 | 2021-03-15 | |
| US63/161,141 | 2021-03-15 | ||
| US202163164125P | 2021-03-22 | 2021-03-22 | |
| US63/164,125 | 2021-03-22 | ||
| PCT/IB2022/000134 WO2022195355A1 (en) | 2021-03-15 | 2022-03-14 | Benzisoxazole derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024509625A JP2024509625A (ja) | 2024-03-04 |
| JP2024509625A5 true JP2024509625A5 (cg-RX-API-DMAC7.html) | 2025-03-24 |
| JP7883513B2 JP7883513B2 (ja) | 2026-07-01 |
Family
ID=81579856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556473A Active JP7883513B2 (ja) | 2021-03-15 | 2022-03-14 | ベンゾイソオキサゾール誘導体及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250276964A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4308559A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7883513B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022195355A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120129677A (zh) | 2022-11-04 | 2025-06-10 | 百时美施贵宝公司 | 化合物及其用于治疗血红素病变的用途 |
| WO2024255810A1 (en) * | 2023-06-15 | 2024-12-19 | Hangzhou Glubio Pharmaceutical Co., Ltd | Dihydropyrimidine-2, 4 (1h, 3h) -dione-containing polycyclic derivatives and pharmaceutical composition thereof, preparation method thereof and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| HUE033177T2 (en) | 2012-01-17 | 2017-11-28 | Astellas Pharma Inc | Pyrazine carboxamide compound |
| IL319363A (en) * | 2017-01-31 | 2025-05-01 | Arvinas Operations Inc | Cervalon ligands and bifunctional compounds containing them |
| CA3082579A1 (en) | 2017-11-15 | 2019-05-23 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| EP3897631A4 (en) | 2018-12-20 | 2022-11-23 | C4 Therapeutics, Inc. | TARGETED PROTEIN BREAKDOWN |
| JP7209897B2 (ja) | 2019-09-12 | 2023-01-20 | メッドシャイン ディスカバリー インコーポレイテッド | Crbnタンパク質モジュレーターとしての二環式化合物 |
| UY39671A (es) | 2021-03-15 | 2022-10-31 | Novartis Ag | Derivados de pirazolopiridina y sus usos. |
-
2022
- 2022-03-14 EP EP22720755.2A patent/EP4308559A1/en active Pending
- 2022-03-14 WO PCT/IB2022/000134 patent/WO2022195355A1/en not_active Ceased
- 2022-03-14 US US18/550,806 patent/US20250276964A1/en active Pending
- 2022-03-14 JP JP2023556473A patent/JP7883513B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509981A5 (cg-RX-API-DMAC7.html) | ||
| JP2023535701A (ja) | 抗ウイルス剤としての官能化ペプチド | |
| JP2024520654A5 (cg-RX-API-DMAC7.html) | ||
| JP2023537402A (ja) | 抗ウイルス剤としての機能化ペプチド | |
| EP3743065A1 (en) | Sulfonamide derivatives for protein degradation | |
| JP2008510018A5 (cg-RX-API-DMAC7.html) | ||
| KR20150082633A (ko) | 경구적으로 생체이용가능한 신규 호흡 조절 제어 화합물 및 그의 사용 방법 | |
| US11434205B2 (en) | Substituted imidazole carboxylate derivatives and the use thereof | |
| KR102304111B1 (ko) | 베타-클로로시클로펜탄의 친수성 에스테르 전구약물의 이용에 의한 감소된 중심 각막 비후 | |
| IL308094A (en) | 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR MEDICAL USES | |
| WO2016130460A9 (en) | Phthalazinone pyrazole derivatives for treating retinal degenerative disease | |
| US20250361218A1 (en) | Agents and methods for treating dysproliferative diseases | |
| US12473305B2 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| JP2025509886A (ja) | サイクリン依存性キナーゼ2阻害剤としてのスルホンアミド誘導体 | |
| JP2019504016A (ja) | アルキルジヒドロキノリンスルホンアミド化合物 | |
| WO2018200571A1 (en) | Substituted 2,3-dihydro-1h-indene analogs and methods using same | |
| JP7661969B2 (ja) | 1,4,5,6-テトラヒドロピリミジン-2-アミン誘導体 | |
| JP2022541311A5 (cg-RX-API-DMAC7.html) | ||
| WO2023141207A1 (en) | Esters of 8-methyl-8-azabicyclo[3.2.1] octan-3-yl 3-hydroxy-2-phenylpropanoate | |
| CN117586204A (zh) | 异硒唑酮类化合物、其合成方法及用途 | |
| EP3107906A1 (en) | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes | |
| EP4470608A1 (en) | Lysophosphatidylserine analogue, and lysophosphatidylserine analogue-containing phamaceutical composition for treating or preventing fibrosis | |
| JP2025529076A (ja) | AhR媒介疾患の治療に使用するタピナロおよびそのアナログ製剤 | |
| CN114341137B (zh) | 二氢嘧啶衍生物及其用途 | |
| RU2023135650A (ru) | Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и способы их применения |